M01AB55 • diclofenac + orfenadrin citrate • Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances
The combination of diclofenac and orphenadrine citrate is used for the treatment of pain and inflammation associated with musculoskeletal conditions. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID), while orphenadrine has muscle relaxant properties.
The medication is administered orally or via injection, as directed by a doctor. It is important to follow the recommended dose to minimize the risk of side effects.
Side effects may include nausea, abdominal pain, dizziness, or drowsiness. In rare cases, severe allergic reactions, gastric ulcers, or renal failure may occur.
This combination is not recommended for patients with active gastric ulcers, severe renal impairment, or hypersensitivity to any of the components.
Substance: diclofenac + orfenadrin citrate
Date of last drug list: 01-10-2019
Commercial code: W60619003
Concentration: 0.3mg / 0.12mg / ml
Pharmaceutical form: solution for infusion
Quantity: 10
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).